Literature DB >> 8923479

Relationship between structure and inhibitory effect of arginine analogues on neuronal nitric oxide synthase activity.

I Yokoi1, Y Namba, H Kabuto, K Inada, M Iida, A Mori, N Ogawa.   

Abstract

Since nitric oxide (NO) is synthesized by nitric oxide synthase (NOS) from L-arginine (Arg) which has an amidino group in its molecule, we examined the effect of 29 kinds of Arg analogues on neuronal NOS (nNOS) activity in the rat brain. None of the Arg analogues acted as a substrate for nNOS. Diamidinocystamine, hirudonine, and guanethidine inhibited nNOS activity to 67.3%, 64.2% and 74.1%, respectively, but their inhibitory efficiency was lower than NG-monomethyl-L-arginine (to 36.5%) which is a well known NOS inhibitor. Dimethylguanidine and N-benzoylguanidine also significantly inhibited nNOS activity to 88.0% and 90.7%, respectively. Whereas almost all of the NOS inhibitors previously reported were synthesized by substituting the amidino nitrogen of Arg, none of these new inhibitors were substituted at this position. Furthermore, hirudonine, which is a naturally occurring compound, was thought to act as an agonist at polyamine binding site of the N-methyl-D-aspartate type of glutamate receptor complex. It is also interesting that guanethidine, an antihypertensive agent, inhibit nNOS activity. These new drugs are useful for the investigation not only of the chemical nature of nNOS but also of the physiologic function of NO.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8923479     DOI: 10.1007/bf02532394

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  25 in total

1.  Biological roles of nitric oxide.

Authors:  S H Snyder; D S Bredt
Journal:  Sci Am       Date:  1992-05       Impact factor: 2.142

2.  Pharmacology of [2-(octahydro-1-azocinyl)-ethyl]-guanidine sulfate (Su-5864).

Authors:  R A MAXWELL; A J PLUMMER; F SCHNEIDER; H POVALSKI; A I DANIEL
Journal:  J Pharmacol Exp Ther       Date:  1960-01       Impact factor: 4.030

3.  Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain.

Authors:  J Garthwaite; S L Charles; R Chess-Williams
Journal:  Nature       Date:  1988-11-24       Impact factor: 49.962

4.  Arcaine is a competitive antagonist of the polyamine site on the NMDA receptor.

Authors:  I J Reynolds
Journal:  Eur J Pharmacol       Date:  1990-02-27       Impact factor: 4.432

5.  Comparison of antihypertensive efficacy, intestinal absorption, and excretion of guanethidine in hypertensive patients.

Authors:  K H Rahn; L I Goldberg
Journal:  Clin Pharmacol Ther       Date:  1969 Nov-Dec       Impact factor: 6.875

6.  Gas chromatography--mass spectrometry of guanidino compounds in brain.

Authors:  A Mori; T Ichimura; H Matsumoto
Journal:  Anal Biochem       Date:  1978-09       Impact factor: 3.365

7.  Delta-guanidinovaleric acid as an endogenous and specific GABA-receptor antagonist: electroencephalographic study.

Authors:  I Yokoi; K Tsuruta; H Shiraga; A Mori; H Shigara
Journal:  Epilepsy Res       Date:  1987-03       Impact factor: 3.045

8.  Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures.

Authors:  V L Dawson; T M Dawson; D A Bartley; G R Uhl; S H Snyder
Journal:  J Neurosci       Date:  1993-06       Impact factor: 6.167

9.  Inhibition of nitric oxide synthesis impairs autoregulation of local cerebral blood flow in the rat.

Authors:  K Tanaka; Y Fukuuchi; S Gomi; B Mihara; T Shirai; S Nogawa; H Nozaki; E Nagata
Journal:  Neuroreport       Date:  1993-03       Impact factor: 1.837

10.  Polyamines regulate glycine interaction with the N-methyl-D-aspartate receptor.

Authors:  R W Ransom; N L Deschenes
Journal:  Synapse       Date:  1990       Impact factor: 2.562

View more
  1 in total

Review 1.  Development of nitric oxide synthase inhibitors for neurodegeneration and neuropathic pain.

Authors:  Paramita Mukherjee; Maris A Cinelli; Soosung Kang; Richard B Silverman
Journal:  Chem Soc Rev       Date:  2014-10-07       Impact factor: 54.564

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.